Christy L. Shaffer's most recent trade in Clearside Biomedical Inc was a trade of 45,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical Inc | Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
CalciMedica Inc | Christy L. Shaffer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 0 | - | - | Restricted Stock Unit | |
CalciMedica Inc | Christy L. Shaffer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 1,429 | - | - | Common Stock | |
Clearside Biomedical Inc | Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
CalciMedica Inc | Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
CalciMedica Inc | Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
Clearside Biomedical Inc | Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
CalciMedica Inc | Christy L. Shaffer | Director | 29 Sep 2020 | 1,586,490 | 1,586,490 | - | - | Common Stock | ||
CalciMedica Inc | Christy L. Shaffer | Director | 29 Sep 2020 | 1,242,120 | 0 | - | - | Series B Preferred Stock | ||
CalciMedica Inc | Christy L. Shaffer | Director | 29 Sep 2020 | 193,224 | 0 | - | - | Series A-2 Preferred Stock | ||
CalciMedica Inc | Christy L. Shaffer | Director | 29 Sep 2020 | 151,146 | 0 | - | - | Series C Preferred Stock | ||
CalciMedica Inc | Christy L. Shaffer | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 29 Sep 2020 | 18,750 | 1,605,240 | - | 16 | 300,000 | Common Stock |